Korea Investment Corp
CRL icon

Korea Investment Corp’s Charles River Laboratories CRL Stock Holding History

Korea Investment Corp’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-26,304
Closed -$4.86M – 724
2024
Q4 		$4.86M Sell
26,304
-42,200
-62% -$8.13M 0.01% 624
2024
Q3 		$13.5M Buy
68,504
+22,347
+48% +$4.64M 0.03% 425
2024
Q2 		$9.54M Buy
46,157
+5,221
+13% +$1.18M 0.02% 467
2024
Q1 		$11.1M Buy
40,936
+15,659
+62% +$3.74M 0.03% 441
2023
Q4 		$5.98M Buy
25,277
+11,228
+80% +$2.21M 0.02% 551
2023
Q3 		$2.75M Sell
14,049
-4,154
-23% -$853K 0.01% 614
2023
Q2 		$3.83M Buy
18,203
+1,249
+7% +$249K 0.01% 567
2023
Q1 		$3.42M Sell
16,954
-2,261
-12% -$512K 0.01% 606
2022
Q4 		$4.19M Sell
19,215
-4,315
-18% -$942K 0.01% 581
2022
Q3 		$4.63M Sell
23,530
-9,687
-29% -$2.09M 0.01% 568
2022
Q2 		$7.11M Buy
33,217
+14,917
+82% +$3.64M 0.02% 489
2022
Q1 		$5.2M Buy
18,300
+5,600
+44% +$1.73M 0.01% 569
2021
Q4 		$4.79M Buy
12,700
+900
+8% +$350K 0.01% 527
2021
Q3 		$4.87M Buy
11,800
+1,000
+9% +$415K 0.01% 515
2021
Q2 		$4M Buy
+10,800
New +$3.61M 0.01% 577

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Korea Investment Corp's CRL Position: Q1 2025 in Review

Korea Investment Corp sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 26,304 shares — an estimated $4.86M sold.

Korea Investment Corp first reported a position in CRL in Q2 2021 and held it in 15 quarters. The position peaked at $13.5M in Q3 2024. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • Korea Investment Corp reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • Korea Investment Corp sold 26,304 Charles River Laboratories shares in Q1 2025, an estimated $4.86M.
  • Korea Investment Corp first reported a position in Charles River Laboratories in Q2 2021 and held it in 15 quarters.
  • Korea Investment Corp's Charles River Laboratories position peaked at $13.5M in Q3 2024.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Korea Investment Corp's 13F filing for Q1 2025, filed 14 May 2025.